Related Experiment Video
Updated: Jun 12, 2026

10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Alternative influenza vaccines made by insect cells
Florian Krammer1, Reingard Grabherr
1Vienna Institute of BioTechnology (VIBT), Department of Biotechnology, University of Natural Resources and Applied Life Sciences, 1190 Vienna, Austria.
Trends in Molecular Medicine
|June 24, 2010
Summary
Emerging influenza strains necessitate improved vaccine production. Insect cell-derived vaccines offer a faster, safer alternative to traditional egg-based methods, enhancing future vaccine supply.
Area of Science:
- Virology
- Vaccinology
- Biotechnology
Background:
- Emerging influenza strains, like swine-origin H1N1, pose significant public health threats.
- Seasonal influenza viruses cause considerable annual morbidity and mortality.
- Traditional egg-derived influenza vaccines, used since the 1940s, face challenges in meeting current demands for speed and yield.
Purpose of the Study:
- To explore alternative production methods for influenza vaccines.
- To investigate insect cell-derived influenza vaccines as a viable option.
- To assess the potential of new approaches for future influenza vaccine supply.
Main Methods:
- Review of established insect cell-derived influenza vaccine approaches.
- Analysis of production methods compared to egg-derived vaccines.
- Evaluation of yield, safety, and speed of insect cell-based systems.
Main Results:
- Insect cell-derived influenza vaccines present a novel alternative to egg-based production.
- Three distinct approaches for insect cell-derived vaccines have been developed.
- These methods show promise for improving vaccine supply and development.
Conclusions:
- Insect cell technology offers a promising avenue for influenza vaccine manufacturing.
- Advancements in insect cell-derived vaccines can address limitations of current production methods.
- These innovative approaches could bolster global capacity for influenza vaccine production.
More Related Videos
Related Concept Videos
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

